Developmental roadmap for antimicrobial susceptibility testing systems.

ABSTRACT: Antimicrobial susceptibility testing (AST) technologies help to accelerate the initiation of targeted antimicrobial therapy for patients with infections and could potentially extend the lifespan of current narrow-spectrum antimicrobials. Although conceptually new and rapid AST technologies have been described, including new phenotyping methods, digital imaging and genomic approaches, there is no single major, or broadly accepted, technological breakthrough that leads the field of rapid AST platform development. This might be owing to several barriers that prevent the timely development and implementation of novel and rapid AST platforms in health-care settings. In this Consensus Statement, we explore such barriers, which include the utility of new methods, the complex process of validating

SUBMITTER: van Belkum A 

PROVIDER: S-EPMC7138758 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature